Austria
will only use Sputnik V vaccine after EMA approval, Kurz says
Send a link to a friend
[April 19, 2021]
VIENNA (Reuters) - Austria will only use
Russia's Sputnik V coronavirus vaccine once the European Medicines
Agency has approved it, Chancellor Sebastian Kurz said on Monday, amid
growing public frustration with the pace of COVID-19 vaccinations.
|
Austria has been in talks with Russia to buy a million doses of the
vaccine, and Kurz said on March 31 the order would probably be
placed the following week. However, that order has yet to be
announced.
Kurz had recently avoided saying whether his country would await EMA
approval of the vaccine, which has been used in the European Union
only by Hungary so far. EMA has launched a rolling review of Sputnik
V.
"We hope it will quickly be approved by EMA as every extra vaccine
dose helps us save lives," Kurz said in a statement, adding that his
conservatives and their coalition partner, the Greens, had agreed to
make the order. A Kurz spokesman confirmed that meant it would only
be used after EMA's approval.
The efficacy of the two-shot Sputnik V vaccine was initially greeted
with scepticism by some Western scientists after Russia approved it
in August last year without waiting for the results of full clinical
trials.
[to top of second column] |
However, scientists said it was
almost 92% effective in fighting COVID-19, based
on peer-reviewed late-stage trial results
published in The Lancet medical journal in
February.
Many European officials still have concerns
about Russia's intentions in exporting it to
dozens of countries when it has yet to vaccinate
most of its own population.
Only two other EU countries, Hungary and
Slovakia, have ordered Sputnik V and only
Hungary has used it. The issue is so
controversial in Slovakia that it sparked a
political crisis that prompted Prime Minister
Igor Matovic to resign last month.
(Reporting by Francois Murphy, Editing by
William Maclean)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |